205 related articles for article (PubMed ID: 25645856)
21. Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
Nanayakkara NP; Tekwani BL; Herath HM; Sahu R; Gettayacamin M; Tungtaeng A; van Gessel Y; Baresel P; Wickham KS; Bartlett MS; Fronczek FR; Melendez V; Ohrt C; Reichard GA; McChesney JD; Rochford R; Walker LA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4737-44. PubMed ID: 24913163
[TBL] [Abstract][Full Text] [Related]
22. A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes.
Bhoopathy S; Xin B; Unger SE; Karnes HT
J Pharm Biomed Anal; 2005 Apr; 37(4):739-49. PubMed ID: 15797796
[TBL] [Abstract][Full Text] [Related]
23. Understanding outliers on the usual dose-response curve: venlafaxine as a way to phenotype patients in terms of their CYP 2D6 status and why it matters.
Preskorn SH
J Psychiatr Pract; 2010 Jan; 16(1):46-9. PubMed ID: 20098230
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluation of a primaquine prodrug without red blood cell membrane destabilization property.
Davanço MG; Campos ML; Nogueira MA; Campos SL; Marques RV; dos Santos JL; Chin CM; da Fonseca LM; Peccinini RG
Biopharm Drug Dispos; 2012 Nov; 33(8):437-45. PubMed ID: 22899089
[TBL] [Abstract][Full Text] [Related]
25. Effects of an NADPH-generating system on primaquine degradation by hamster liver fractions.
Abu-El-Haj S; Allahyari R; Chavez E; Fraser IM; Strother A
Xenobiotica; 1988 Oct; 18(10):1165-78. PubMed ID: 3242312
[TBL] [Abstract][Full Text] [Related]
26. In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differences.
Mehrotra N; Lal J; Puri SK; Madhusudanan KP; Gupta RC
Biopharm Drug Dispos; 2007 Jul; 28(5):209-27. PubMed ID: 17410524
[TBL] [Abstract][Full Text] [Related]
27. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver.
Gomes F; Ribeiro AC; Sanches GS; Borges HS; Takahashi LAU; Daniel-Ribeiro CT; Tedesco AC; Nascimento JWL; Carvalho LJM
Antimicrob Agents Chemother; 2024 May; 68(5):e0091523. PubMed ID: 38517190
[TBL] [Abstract][Full Text] [Related]
28. An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model.
Jin X; Pybus BS; Marcsisin R; Logan T; Luong TL; Sousa J; Matlock N; Collazo V; Asher C; Carroll D; Olmeda R; Walker LA; Kozar MP; Melendez V
Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):139-46. PubMed ID: 23797843
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism of cytochrome P450 2D6 determines oestrogen receptor activity of the major infertility drug clomiphene via its active metabolites.
Mürdter TE; Kerb R; Turpeinen M; Schroth W; Ganchev B; Böhmer GM; Igel S; Schaeffeler E; Zanger U; Brauch H; Schwab M
Hum Mol Genet; 2012 Mar; 21(5):1145-54. PubMed ID: 22108178
[TBL] [Abstract][Full Text] [Related]
30. Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes.
Fasinu PS; Avula B; Tekwani BL; Nanayakkara NP; Wang YH; Bandara Herath HM; McChesney JD; Reichard GA; Marcsisin SR; Elsohly MA; Khan SI; Khan IA; Walker LA
Malar J; 2016 Apr; 15():224. PubMed ID: 27093859
[TBL] [Abstract][Full Text] [Related]
31. [Genotoxicity and activation of organophosphate and carbamate pesticides by cytochrome P450 2D6].
Costa C; Catania S; Silvari V
G Ital Med Lav Ergon; 2003; 25 Suppl(3):81-2. PubMed ID: 14979094
[TBL] [Abstract][Full Text] [Related]
32. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
[TBL] [Abstract][Full Text] [Related]
33. Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice.
Fasinu PS; Chaurasiya ND; Dhammika Nanayakkara NP; Wang YH; Bandara Herath HMT; Avula B; McChesney JD; Jollow D; Walker LA; Tekwani BL
Malar J; 2022 Feb; 21(1):33. PubMed ID: 35123453
[TBL] [Abstract][Full Text] [Related]
34. Prediction of drug metabolism: the case of cytochrome P450 2D6.
Vermeulen NP
Curr Top Med Chem; 2003; 3(11):1227-39. PubMed ID: 12769702
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
[TBL] [Abstract][Full Text] [Related]
36. The effect of malaria-induced alteration of metabolism on piperaquine disposition in Plasmodium yoelii infected mice and predicted in malaria patients.
Xie Y; Zhang Y; Lin F; Chen X; Xing J
Int J Antimicrob Agents; 2024 Jul; 64(1):107209. PubMed ID: 38761871
[TBL] [Abstract][Full Text] [Related]
37. Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers.
Khan W; Wang YH; Chaurasiya ND; Nanayakkara ND; Herath HB; Harrison KA; Dale G; Stanford DA; Dahl EP; McChesney JD; Gul W; ElSohly MA; Khan SI; Fasinu PS; Khan IA; Tekwani BL; Walker LA
Drug Metab Pharmacokinet; 2022 Aug; 45():100463. PubMed ID: 35709685
[TBL] [Abstract][Full Text] [Related]
38. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.
Preskorn S; Patroneva A; Silman H; Jiang Q; Isler JA; Burczynski ME; Ahmed S; Paul J; Nichols AI
J Clin Psychopharmacol; 2009 Feb; 29(1):39-43. PubMed ID: 19142106
[TBL] [Abstract][Full Text] [Related]
40. Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans.
Werner U; Werner D; Rau T; Fromm MF; Hinz B; Brune K
Clin Pharmacol Ther; 2003 Aug; 74(2):130-7. PubMed ID: 12891223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
